Blended learning for entrepreneurial biomedical professionalss
Paul Janssen Futurelab Leiden offers a non-profit, international blended learning program for tomorrow’s leaders in biomedical science who have the ambition to develop a new medical intervention.
Featured course
Featured tool
Featured
Market Approval
Market Approval Navigator
The Market Approval Navigator is designed as a practical and easy to use tool to quickly identify relevant documents for market approval of biomedical interventions. Guidelines and guidance documents from European Medicines Agency (EMA), US Food and Drug Administration (FDA) and International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) can be searched simultaneously for 1 or several key words. Watch the tutorial to get started or create an account to use the tool for free.
Our approach in professional learning
We offer a unique blend of online education and on-campus training for talented biomedical scientist that have the ambition to become the future generation Chief Scientific Officers.
Read more
Our participants
Learn more about our participants
On-campus experience
Further explore the concepts of the online courses during the on-campus course. Maximum 30 participants are invited to castle Oud-Poelgeest near Leiden, the Netherlands to work in small, multidisciplinary focus groups on advanced teaching cases that are based on real R&D project.
Read more
A selection of our contributors
Marc Martens
Head of Bird & Bird's Regulatory, Public & Administrative Law group in Brussels
Bird & Bird
Aliki Nichogiannopoulou
Director
European Patent Office
Ton van der Hoven
CEO
SurgVision BV
Bruno Vandermeulen
IP Lawyer - Member of the Brussels Bar
Independent IP practitioner
On-campus
Nacer Lounis
Senior Principal Scientist
Janssen Pharmaceutica
On-campus
Tine de Marez
Senior Director, Compound Development Team Leader TB
Johnson & Johnson
Bert Leufkens
Professor of Pharmaceutical Policy and Regulatory Science and Former Chair of Medicines Evaluation Board
Utrecht Institute for Pharmaceutical Sciences (UIPS)
Henk Schuring
VP-Head Rare Nephrology
Sanofi Genzyme
Sjaak Bot
VP, Head of EMEA Regulatory Affairs
Janssen
Bernd van der Meulen
Professor of Comparative Food Law
European Institute for Food Law / Renmin University of China Law School
Frank Landolt
Chief Counsel Legal & Intellectual Property
Confo Therapeutics
On-campus
Erik Niks
Neurologist - Pediatric neurologist
Leiden University Medical Center
On-campus
Piet Hinoul
Global Head, Pre-Clinical, Clinical and Medical Affairs
J&J Ethicon
On-campus
Ad Sitsen
Owner
ClinPharMed Consultancy for Drug Development
Eline Bunnik
Assistant professor Medical Ethics and Philosophy of Medicine
Erasmus MC
Maurits Westerik
IE/IT lawyer
Coupry
Bart Swinkels
Partner
NLO
Karin Verzijden
Food and Pharma Lawyer
Axon Lawyers
On-campus
Ineke Jonker-Hoogerkamp
Consultant Regulatory Affairs and Drug Development
Paul Janssen Futurelab & Eagle Pharma Consult
Kees Recourt
Investment Manager
Mibiton Foundation
Paul Stoffels
Chief scientific officer
Johnson & Johnson
Tom Huizinga
Head of the Department of Rheumatology
Leiden University Medical Centre
On-campus
Marcel Kenter
Director
Paul Janssen Futurelab Leiden
On-campus
Koen Andries
VP Scientific Fellow Infectious Diseases Discovery
Janssen Pharmaceutica NV
On-campus
Andreas Wallnöfer
General Partner
BioMed Partners Venture Capital (former Head of Clinical Research & Exploratory Development at F. Hoffmann-La Roche Ltd.)
On-campus
Justin Hay
Pharmacokinetics Assessor
Medicines and Healthcare products Regulatory Agency
On-campus
André Elferink
Clinical epidemiologist
Dutch Medicines Evaluation Board
On-campus
Rob Zuiker
Senior Clinical Scientist
CHDR
On-campus
Barbara J. van Zwieten-Boot
Vice Chair
Medicines Evaluation Board, The Netherlands
Hans-Georg Eichler
Senior Medical Officer
European Medicines Agency
On-campus
Robert Klautz
Thoracic Surgeon
Leiden University Medical Centre
On-campus
Matthijs Moerland
Research Director Translational Biomarkers
CHDR
Joris Rotmans, MD, PhD
internist-nephrologist
LUMC
On-campus
Janneke Meulenberg
CEO
Arthrogen
Inge de Lepeleire
Director Translational Pharmacology
MSD Europe
On-campus
Koos Burggraaf
Research Director CVS & Metabolism
CHDR
Johan Garssen
Director Immunology Platform
Danone/Nutricia Research
On-campus
Ingrid de Visser
Senior Clinical Scientist
CHDR
Rick Kuntz
Senior Vice President and Chief Scientific, Clinical and Regulatory Officer
Medtronic
On-campus
Paul de Koning
Exploratory Development Expert
Former Head Clinical Pharmacology & Exploratory Development Astellas
On-campus
Geert Jan Groeneveld
Research Director CNS
CHDR
Oliver Bisazza
Director Regulatory Policy
Medtronic
Saco de Visser
Teacher and Clinical Pharmacologist
Paul Janssen Futurelab Leiden
On-campus
Adam Cohen
CEO and clinical pharmacologist
Centre for Human Drug Research
Richard Shull
Head of Deal Structuring and Trading Fundamentals
Shell
Pierre Peeters
Former site head early stage development
Organon
Really instructive
"The highlights of the course were the real life examples and the follow up provided. The interviews with people that were involved in the studies were really instructive"
Georges Habineza Ndikuyeze, Janssen Research & Development, Clinical Development Online graduate
Very helpful
"The cases were very helpful, they brought the theory to life!"
Dennie Tempel, Quorics B.V., Clinical Development Online graduate
Genuinely fascinating
“The case studies were all thought provoking, well-chosen and expertly presented to make different points. Genuinely fascinating: thanks!”
Huw Lewis, GlaxoSmithKline Clinical Development Online graduate
A world of knowledge
"This training opened my eyes to a whole new world of knowledge on the development of medical interventions"
Willem Birkhoff, Centre for Human Drug Research, Clinical Development Online graduate
Recent tweets Follow @FuturelabLeiden
LUMC constructs the largest stem cell facility for the Netherlands and beyond https://t.co/WcAweEjvUs @LUMC #NECSTGEN https://t.co/WcAweEjvUs
A few days left to sign up for the online course of May 4th. Participants rate this course 9 out of 10. Learn how Question Based Clinical Development can optimize the development of medical products and how to apply it to real R&D projects. https://t.co/M2DQ3uViLE
In collaboration with CCMO, Futurelab offers a FREE COURSE about legislation and procedures on clinical research in the Netherlands. Brush up on how to submit your research file with this short animation. https://t.co/WkF0I0IP3E